Podcast

Type 1 Diabetes and Running Marathons

Scott Hanselman of ComputerZen.com discusees running marathons as a patient with type 1 diabetes.

Scott Hanselman of ComputerZen.com discusees running marathons as a patient with type 1 diabetes with fellow diabetic Gary Schmidt.

Click here to access this third-party resource.

Related Videos
Pranav Garimella, MBBS, MPH | Credit: GlobalNewsWire
Advocating for Race-Neutral Approach to Pulmonary Function Testing with Meredith McCormack, MD, and Loretta Que, MD
Skin of Color Savvy: The Art and Science of Treating Patients of Color
Looking at This Year in Pulmonology: A Lungcast 2024 Recap
Yehuda Handelsman, MD: Insulin Resistance in Cardiometabolic Disease and DCRM 2.0 | Image Credit: TMIOA
Laurence Sperling, MD: Expanding Cardiologists' Role in Obesity Management | Image Credit: Emory University
Schafer Boeder, MD: Role of SGLT2 Inhibitors and GLP-1s in Type 1 Diabetes | Image Credit: UC San Diego
Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis | Image Credit: Lundquist Institute
Alice Cheng, MD: Exploring the Link Between Diabetes and Dementia | Image Credit: LinkedIn
Related Content
The HCPFive: Top News for Healthcare Providers from the Week of 1/26
February 1st 2025

The HCPFive: Top News for Healthcare Providers from the Week of 1/26

HCPLive Editorial Staff
Diabetes Dialogue: Understanding Semaglutide (Ozempic) in CKD and T2D
January 31st 2025

Diabetes Dialogue: Understanding Semaglutide (Ozempic) in CKD and T2D

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES Natalie Bellini, DNP, FNP-BC, BC-ADM, CDCE
Enobosarm Protects Lean Mass in Topline Phase 2b Trial Results | Image Credit: Weill Cornell Medicine
January 27th 2025

Enobosarm Protects Lean Mass in Topline Phase 2b Trial Results

Connor Iapoce
Ep 16: A Look at Qlosi for Presbyopia with Elad Kedar, MBA| Image Credit: HCPLive
January 28th 2025

New Insight: A Look at Qlosi for Presbyopia with Elad Kedar, MBA

Veeral Sheth, MD, MBA, FASRS, FACS Connor Iapoce
Patient Factors Influence Semaglutide Initiation After Obesity Diagnosis | Image Credit: Boston University
January 21st 2025

Patient Factors Influence Semaglutide Initiation After Obesity Diagnosis

Connor Iapoce
Semaglutide 7.2 mg Exhibits 20.7% Weight Loss in Phase 3b STEP UP Trial | Image Credit: Novo Nordisk
January 17th 2025

Semaglutide 7.2 mg Displays 20.7% Weight Loss in Phase 3b STEP UP Trial

Connor Iapoce
© 2025 MJH Life Sciences

All rights reserved.